Few & Far Between: Conversations from the Front Lines of Drug Development
Chris O'Brien
35 episodes
1 day ago
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
All content for Few & Far Between: Conversations from the Front Lines of Drug Development is the property of Chris O'Brien and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures
Few & Far Between: Conversations from the Front Lines of Drug Development
43 minutes 29 seconds
10 months ago
Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures
"There's that old saying, 'culture is how people behave when nobody's looking.' So, if you want to be effective, your [mission and value statements] have to be specific enough to actually guide behavior." - Ben Olds, Executive Coach and Managing Partner, Haven Human Asset Ventures
Welcome back to Biorasi's Few & Far Between podcast. On today's episode, host Chris O'Brien welcomes Ben Olds and Amy Fenollosa from Haven Human Asset Ventures.
Tune in for an in-depth discussion on the challenges CEOs and other biotech leaders face in building a successful company culture - from guiding behavior to creating safe spaces for innovative ideas.
Looking for more information? Be sure to check out the following titles recommended by Ben and Amy in this episode:
"Thanks for the Feedback: The Science and Art of Receiving Feedback Well," by Douglas Stone and Sheila Heen
"Right Kind of Wrong: The Science of Failing Well," by Amy Edmondson
Few & Far Between: Conversations from the Front Lines of Drug Development
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
